loadpatents
Patent applications and USPTO patent grants for Koszalka; George W..The latest application filed is for "method for treating t-cell lymphoblastic leukemia with ara-g nucleoside derivatives".
Patent | Date |
---|---|
Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives Grant 5,492,897 - Krenitsky , et al. February 20, 1 | 1996-02-20 |
Method for the treatment of protoza infections with 2.sup.1 -deoxy-2.sup.1 -fluoropurine nucleosides Grant 5,420,115 - Tisdale , et al. May 30, 1 | 1995-05-30 |
Therapeutic nucleosides Grant 5,185,437 - Koszalka , et al. February 9, 1 | 1993-02-09 |
Therapeutic nucleosides Grant 5,071,983 - Koszalka , et al. December 10, 1 | 1991-12-10 |
2-amino-6-(cyclopropylamino)purine-9-.beta.-D-2',3'-dideo xyribofuranoside and its pharmaceutically acceptable salts Grant 5,068,320 - Koszalka , et al. November 26, 1 | 1991-11-26 |
2,6-diaminopurine-9-.beta.-D-2',3'-dideoxyribofuranoside Grant 4,920,210 - Koszalka , et al. April 24, 1 | 1990-04-24 |
F-substituted-3-.beta.-D-ribofuranosyl-3H-imidazo[4,5-b]pyridines and pharmaceutical compositions thereof Grant 4,780,452 - Krenitsky , et al. October 25, 1 | 1988-10-25 |
SEC | 0001294626 | Koszalka George W |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.